Your browser doesn't support javascript.
loading
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
Uher, Tomas; Horakova, Dana; Tyblova, Michaela; Zeman, David; Krasulova, Eva; Mrazova, Katerina; Seidl, Zdenek; Vaneckova, Manuela; Krasensky, Jan; Weinstock-Guttman, Bianca; Ramanathan, Murali; Havrdova, Eva; Zivadinov, Robert.
Afiliación
  • Uher T; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic/Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY, USA.
  • Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
  • Tyblova M; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
  • Zeman D; Department of Neurology, University Hospital, Ostrava, Czech Republic.
  • Krasulova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
  • Mrazova K; Department of Clinical Biochemistry, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
  • Seidl Z; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
  • Vaneckova M; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
  • Krasensky J; Department of Radiology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
  • Weinstock-Guttman B; Department of Neurology, State University of New York, Buffalo, NY, USA.
  • Ramanathan M; Department of Neurology, State University of New York, Buffalo, NY, USA/Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, USA.
  • Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Czech Republic.
  • Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY, USA/MR Imaging Clinical Translational Research Center, State University of New York, Buffalo, NY, USA rzivadinov@bnac.net.
Mult Scler ; 22(6): 770-81, 2016 05.
Article en En | MEDLINE | ID: mdl-26362893
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Encéfalo / Barrera Hematoencefálica / Progresión de la Enfermedad / Albúminas / Esclerosis Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Encéfalo / Barrera Hematoencefálica / Progresión de la Enfermedad / Albúminas / Esclerosis Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos